A Highly Sensitive and Drug-Tolerant Anti-Drug Antibody Screening Assay for Ixekizumab using Affinity Capture Elution

J Invest Dermatol. 2016 Jul;136(7):1513-1515. doi: 10.1016/j.jid.2016.01.040. Epub 2016 Mar 30.

Authors

Affiliations

¹ Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, USA. Electronic address: [email protected].
² Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, USA.
³ Oregon Medical Research Center, Portland, Oregon, USA.
⁴ Probity Medical Research, Waterloo, Ontario, Canada.

PMID: 27039261
DOI: 10.1016/j.jid.2016.01.040

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Animals
Antibodies / analysis*
Antibodies, Monoclonal, Humanized / immunology*
Haplorhini
Humans
Sensitivity and Specificity

Substances

Antibodies
Antibodies, Monoclonal, Humanized
ixekizumab